Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FD5PP
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,943
Award facts
- Contract value 100% obligated
- $6,943.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $6,943.10 by the Defense Logistics Agency for the supply of Nexplanon 68 mg implants. The contract, issued on August 5, 2025, with an ultimate completion date of August 26, 2025, carries no set-aside designation. This delivery order represents one of numerous pharmaceutical supply contracts awarded to DMS Pharmaceutical Group through the Defense Logistics Agency's SPE2DB Indefinite Delivery Contract program, a $499.999 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting Department of Defense healthcare facilities.
DMS Pharmaceutical Group's role as a prime contractor under this delivery order underscores its established position as a critical supplier within the federal pharmaceutical supply chain. The company leverages its status as a woman-owned small business to compete effectively in federal procurement markets while maintaining consistent contract performance across a broad portfolio of medical products, including contraceptive devices, oncology treatments, vaccines, and specialty pharmaceuticals distributed to military health facilities nationwide. The Nexplanon implant delivery under this order fulfills specific pharmaceutical supply requirements for Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FD5PP?
SPE2DB25FD5PP was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 5, 2025.
How much is contract SPE2DB25FD5PP worth?
The government has obligated $6,943 on SPE2DB25FD5PP.
Is contract SPE2DB25FD5PP an order under another contract?
Yes. SPE2DB25FD5PP is a delivery order under SPE2DB20D9759, an indefinite delivery contract.
Was contract SPE2DB25FD5PP competed?
The extent of competition for SPE2DB25FD5PP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award